Should You Buy AbbVie Stock Hand Over Fist Before July 31?
The recent rally could pave the way for "sell the news" volatility, but don't let this scare you out of a long-term position.
Overview
Before the market opens on July 31, AbbVie (NYSE: ABBV) will report second-quarter results, hoping to build on the momentum from its Q1 earnings beat. As the key catalyst behind last quarter's performance remains in motion, the same could repeat when second-quarter results hit the Street.
But there could be a problem -- just a few weeks ago, management warned about the negative impact of one-time charges on the upcoming earnings release. Shares have continued to rally despite the warnings, but considering this and other factors, the stock could experience some post-earnings turbulence.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.